A multicenter study provides evidence of a relationship between the presence of progesterone and estrogen receptors with overall survival in ovarian cancer patients; progesterone receptor has been associated to better prognosis in endometrioid and high grade serous carcinoma and estrogen receptor with higher overall survival in endometrioid carcinoma [12]. This evidence concerns the gene PGR and endometrioid adenocarcinoma.